Private Advisor Group
AZR icon

Private Advisor Group’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Private Advisor Group’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-34
Closed -$7K – 1671
2022
Q3 		$7K Hold
34
– – ﹤0.01% 1897
2022
Q2 		$29K Sell
34
-21
-38% -$19K ﹤0.01% 2052
2022
Q1 		$69K Hold
55
– – ﹤0.01% 2025
2021
Q4 		$92K Sell
55
-2
-4% -$3.94K ﹤0.01% 2032
2021
Q3 		$152K Sell
57
-2
-3% -$4.19K ﹤0.01% 1913
2021
Q2 		$93K Hold
59
– – ﹤0.01% 1908
2021
Q1 		$89K Buy
+59
New +$89.2K ﹤0.01% 1813

Other funds holding AZR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Raffa Wealth Management
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Private Advisor Group's AZR Position: Q4 2022 in Review

Private Advisor Group sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q4 2022, closing a stake of 34 shares — an estimated $7K sold.

Private Advisor Group first reported a position in AZR in Q1 2021 and held it in 7 quarters. The position peaked at $152K in Q3 2021. 21 funds tracked by Wall St. Rank hold AZR as of Q4 2022.

  • Private Advisor Group reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Private Advisor Group sold 34 Azora Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $7K.
  • Private Advisor Group first reported a position in Azora Therapeutics, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
  • Private Advisor Group's Azora Therapeutics, Inc. Common Stock position peaked at $152K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Private Advisor Group's 13F filing for Q4 2022, filed 18 Jan 2023.